Sunwin International Neutraceuticals and Wild Flavors have received official notification defined as “Letters of No Objection” from the U.S. Food and Drug Administration (FDA) that the agency has reviewed the companies extensive independent research submission and agree that Sunwin Stevia Extracts are Generally Recognized As Safe (GRAS). The FDA letters of no objection affirm the safety of Sunwin Stevia Extracts and the data used in supporting that determination.
Sunwin and Wild Flavors received “Letters of No Objection” GRAS affirmation on five stevia extract products, including their Rebaudioside A 98, Rebaudioside A 95, Rebaudioside A 80, Rebaudioside A 60, and Stevioside 90 Stevia Extracts. Sunwin and Wild have a successful track record producing, marketing and selling these and other extracts in the global stevia markets. This diverse FDA GRAS affirmed product family now allows Sunwin and its partner Wild Flavors to offer global customers an array of options for consumer products sold to US consumers. By offering these high grade extracts, Wild Flavors can work with food and beverage companies to develop customized sweetening systems meeting specific taste, price and caloric goals, which are projected to be strong competitive advantages in the market place.
